Fluoxetine as a treatment for bulimia nervosa. 1987

C P Freeman, and M Hampson
Department of Psychiatry, Royal Edinburgh Hospital, Scotland, UK.

The results of a small study using fluoxetine in the treatment of bulimia nervosa are presented. Ten subjects were treated on an open basis with fluoxetine 60-80 mg daily. Seven subjects stopped their bulimic behaviour completely, two improved and one was unchanged. The results indicate that fluoxetine may have a role in the treatment of bulimia and that further investigation is warranted. A brief review of other drug studies on bulimia nervosa is presented.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011437 Propylamines Derivatives of propylamine (the structural formula NH2CH2CH2CH3).
D002032 Bulimia Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as "ox hunger". Binge Eating,Bulimias,Eating, Binge
D005260 Female Females
D005473 Fluoxetine The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants. Fluoxetin,Fluoxetine Hydrochloride,Lilly-110140,N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine,Prozac,Sarafem,Lilly 110140,Lilly110140
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant

Related Publications

C P Freeman, and M Hampson
May 1995, The British journal of psychiatry : the journal of mental science,
C P Freeman, and M Hampson
January 1991, Journal of psychosomatic research,
C P Freeman, and M Hampson
December 2006, Prescrire international,
C P Freeman, and M Hampson
December 1990, Journal of clinical psychopharmacology,
C P Freeman, and M Hampson
January 1993, International clinical psychopharmacology,
C P Freeman, and M Hampson
August 2000, The American journal of psychiatry,
C P Freeman, and M Hampson
November 2002, Evidence-based mental health,
C P Freeman, and M Hampson
January 2003, Journal of child and adolescent psychopharmacology,
Copied contents to your clipboard!